Use of a platform in an automated open-field to enhance assessment of anxiety-like behaviors in mice

Journal of Neuroscience Methods

Volumn 162, Issue 1-2, 2007, Pages 222-228

  Pogorelov, Vladimir M ^a   Lanthorn, Thomas H ^a   Savelieva, Katerina V ^a  

^a LEXICON PHARMACEUTICALS INC   (United States)

Author keywords

Anxiety; Anxiolytic; Exploration; Light dark test; Mice; Open field

Indexed keywords

AMPHETAMINE; ANXIOLYTIC AGENT; BUSPIRONE; CHLORDIAZEPOXIDE; IMIPRAMINE;

ANIMAL EXPERIMENT; ANXIETY; ARTICLE; BEHAVIOR; FEMALE; FUNCTION TEST; GENDER; ILLUMINATION; LABORATORY; LOCOMOTION; MALE; MOTOR ACTIVITY; MOUSE; MOUSE STRAIN; NONHUMAN; PHENOTYPE; PLATFORM TEST; PRIORITY JOURNAL; SEDATION;

ANIMALS; ANXIETY; AUTOMATION; CROSSES, GENETIC; DARKNESS; DEXTROAMPHETAMINE; DISEASE MODELS, ANIMAL; FEMALE; LIGHT; LIGHTING; MALE; MICE; MICE, INBRED C57BL; MOTOR ACTIVITY; SEX CHARACTERISTICS;

EID: 34047141499     PISSN: 01650270     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneumeth.2007.01.015     Document Type: Article

References (19)

1. Bakshi V.P., and Kalin N.H. Animal models and endophenotypes of anxiety and stress disorders. In: Davis K.L., Charney D., Coyle J.T., and Nemeroff C. (Eds). Neuropsychopharmacology: the fifth generation of progress. 5th ed. vol. 62 (2002), Lippincott Williams & Wilkins, Philadelphia (PA) 884-901
2. Beglopoulos V., and Shen J. Gene-targeting technologies for the study of neurological disorders. Neuromol Med 6 (2004) 13-30
3. Belzung C., and Griebel G. Measuring normal and pathological anxiety-like behavior in mice: a review. Behav Brain Res 125 (2001) 141-149
4. Bhatnagar S., Nowak N., Babich L., and Bok L. Deletion of the 5-HT3 receptor differentially affects behavior of males and females in the Porsolt forced swim and defensive withdrawal tests. Behav Brain Res 153 (2004) 535-537
5. Bothe G.W., Bolivar V.J., Vedder M.J., and Geistfeld J.G. Genetic and behavioral differences among five inbred mouse strains commonly used in the production of transgenic and knockout mice. Genes Brain Behav 3 (2004) 149-157
6. Capecchi M.R. Gene targeting in mice: functional analysis of the mammalian genome for the 21st century. Nat Rev Genet 6 (2005) 507-512
7. Chapouthier G., Bondoux G., Martin B., Desforges C., and Launay J.M. Genetic difference in sensitivity to beta-carboline: evidence for the involvement of brain benzodiazepine receptors. Brain Res 553 (1991) 342-346
8. Crawley J.N. Neuropharmacologic specificity of a simple animal model for the behavioral actions of benzodiazepines. Pharmacol Biochem Behav 15 (1981) 695-699
9. File S.E., Lippa A.S., Beer B., and Lippa M.T. Animal tests of anxiety. In: Taylor G.P. (Ed). Current protocols in neuroscience (2000), John Wiley & Sons Inc., New York 8.3.1-8.3.19
10. Hascoet M., and Bourin M. A new approach to the light/dark test procedure in mice. Pharmacol Biochem Behav 60 (1998) 645-653
11. Kilfoil T., Michel A., Montgomery D., and Whiting R.L. Effects of anxiolytic and anxiogenic drugs on exploratory activity in a simple model of anxiety in mice. Neuropharmacology 28 (1989) 901-905
12. Kliethermes C.L., Finn D.A., and Crabbe J.C. Validation of a modified mirrored chamber sensitive to anxiolytics and anxiogenics in mice. Psychopharmacology 169 (2003) 190-197
13. Pokk P., and Zharkovsky A. The effects of buspirone on the behaviour of control and stressed mice. J Physiol Pharmacol 49 (1998) 175-185
14. Prut L., and Belzung C. The open field as a paradigm to measure the effects of drugs on anxiety-like behaviors: a review. Eur J Pharmacol 463 (2003) 3-33
15. Simon P., Dupuis R., and Costentin J. Thigmotaxis as an index of anxiety in mice. Influence of dopaminergic transmissions. Behav Brain Res 61 (1994) 59-64
16. Stone E.A., Najimi M., and Quartermain D. Potentiation by propranolol of stress-induced changes in passive avoidance and open field emergence tests in mice. Pharmacol Biochem Behav 51 (1995) 297-300
17. Takahashi L.K., Ho S.P., Livanov V., Graciani N., and Arneric S.P. Antagonism of CRF receptors produces anxiolytic behavior in animal 2 models of anxiety. Brain Res 902 (2001) 135-142
18. Young R., and Johnson D.N. A fully automated light/dark apparatus useful for comparing anxiolytic agents. Pharmacol Biochem Behav 40 (1991) 739-743
19. Zambrowicz B.P., and Sands A.T. Knockouts model the 100 best-selling drugs-will they model the next 100?. Nat Rev Drug Discov 2 (2003) 38-51